Trimedyne, Inc. announced financial results for the quarter and six months ending on March 31, 2019. For the quarter, the company had revenues of $1,396,000, an increase of 3% from revenues of $1,352,000 for the prior year quarter. Company had a net loss for the current quarter of $93,000 or $0.76 loss per share, as compared to net income of $24,000 or $0.20 per share for the prior year quarter. For the six-month period ended March 31, 2019, the company had revenues of $2,584,000, a decrease of 10% from revenues of $2,886,000 for the prior year six-month period.  Company had a net loss for the current six-month period of $124,000 or $1.01 loss per share, as compared to net income of $110,000 or $0.90 per share for the prior year six-month period.